Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| Improving time- and cost-efficiency in doping analysis | 2016 - 2019 | Industrial Researcher
|
|
|
Improving time- and cost-efficiency in doping analysis
Period
2016 - 2019
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
78.31 Invested
1.1 mill. Budget
1.4 mill. Partners
Københavns Universitet, Anti Doping Danmark People
Anti Doping Danmark
Read more about the project
| |||
| Individuel smerte profil måling med det formål at kunne forbedre smerte behandling | 2018 - 2019 | Innobooster
|
|
|
Individuel smerte profil måling med det formål at kunne forbedre smerte behandling
Period
2018 - 2019
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
32.8 Invested
152.500 Budget
465.000 Partners
Nocitech Aps People
NOCITECH ApS
Read more about the project
| |||
| Industrial PhD: Corti ApS - Jakob Drachmann Havtorn | 2020 - 2023 | Industrial Researcher
|
|
|
Industrial PhD: Corti ApS - Jakob Drachmann Havtorn
Period
2020 - 2023
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
1.1 mill. Budget
1.1 mill. Partners
Technical University of Denmark, Corti ApS People
Corti ApS
Read more about the project
| |||
| Influenz-er Influenz-er: Rethinking Epidemic Preparedness and Response | 2020 - 2024 | Grand Solutions
|
|
|
Influenz-er Influenz-er: Rethinking Epidemic Preparedness and Response
Period
2020 - 2024
Region
Region Hovedstaden Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
74.7 Invested
19.1 mill. Budget
25.5 mill. Partners
Nordsjællands Hospital, University of Southern Denmark People
Region Hovedstaden
Read more about the project
| |||
| Injectable stem cell derived beta-cell patch with controlled release function to enhance cell survival and functionality during transplantation | 2020 - 2023 | Industrial Researcher
|
|
|
Injectable stem cell derived beta-cell patch with controlled release function to enhance cell survival and functionality during transplantation
Period
2020 - 2023
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
50.09 Invested
1.1 mill. Budget
2.1 mill. Partners
Aarhus University, Novo Nordisk A/S - G8, x9 m.fl. People
Novo Nordisk A/S - G8, x9 m.fl.
Read more about the project
| |||
| Inline digital label print til Late Stage Customization | 2019 - 2020 | Innobooster
|
|
|
Inline digital label print til Late Stage Customization
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
32 Invested
480.000 Budget
1.5 mill. Partners
PPS A/S People
PROFESSIONAL PACKAGING SYSTEMS A/S
Read more about the project
| |||
| InnoboosterMLv2 | 2019 - 2021 | Innobooster
|
|
|
InnoboosterMLv2
Period
2019 - 2021
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
1.1 mill. Budget
3.5 mill. Partners
CareIndexing ApS People
CareIndexing ApS
Read more about the project
| |||
| Innogait | 2020 - 2020 | Innobooster
|
|
|
Innogait
Period
2020 - 2020
Region
Region Nordjylland Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
30.56 Invested
458.370 Budget
1.5 mill. Partners
Nordic NeuroStim People
Nordic-Neurostim ApS
Read more about the project
| |||
| Innovative statistical methods for assessing post approval drug safety based on real world user data | 2019 - 2022 | Industrial Researcher
|
|
|
Innovative statistical methods for assessing post approval drug safety based on real world user data
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
62.19 Invested
1.1 mill. Budget
1.7 mill. Partners
Københavns Universitet, LEO PHARMA A/S People
LEO PHARMA A/S
Read more about the project
| |||
| Inprother: Treating cancer by targeting tumor viruses within our genome | 2019 - 2020 | Innobooster
|
|
|
Inprother: Treating cancer by targeting tumor viruses within our genome
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
27.6 Invested
4.0 mill. Budget
14.3 mill. Partners
Inprother Aps People
INPROTHER ApS
Read more about the project
| |||
| Insulin, Novel IBD Therapy | 2019 - 2020 | Innobooster
|
|
|
Insulin, Novel IBD Therapy
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
32.95 Invested
484.400 Budget
1.5 mill. Partners
EnteroTarget ApS People
EnteroTarget ApS
Read more about the project
| |||
| Intelligence augmentation in healthcare – bridging the deployment gap between AI research and clinical practice | 2018 - 2021 | Industrial Researcher
|
|
|
Intelligence augmentation in healthcare – bridging the deployment gap between AI research and clinical practice
Period
2018 - 2021
Region
Region Midtjylland Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
51.1 Invested
1.1 mill. Budget
2.1 mill. Partners
Aarhus Universitet, ENVERSION A/S People
ENVERSION A/S
Read more about the project
| |||
| Intelligent Shuntplaster | 2020 - 2021 | Innoexplorer
|
|
|
Intelligent Shuntplaster
Period
2020 - 2021
Region
Region Nordjylland Program
Innoexplorer Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
1.5 mill. Budget
1.5 mill. Partners
Aalborg Universitetshospital Syd People
Aalborg Universitetshospital Syd
Read more about the project
| |||
| Interactive Meditation apps for AppleWatch | 2019 - 2020 | Innobooster
|
|
|
Interactive Meditation apps for AppleWatch
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
32.68 Invested
500.000 Budget
1.5 mill. Partners
PauseAble ApS People
PauseAble ApS
Read more about the project
| |||
| Introducing a FAS ligand hexameric (APO010) and companion diagnostics for the immunotherapy of Metastatic Breast Cancer | 2016 - 2019 | Industrial Researcher
|
|
|
Introducing a FAS ligand hexameric (APO010) and companion diagnostics for the immunotherapy of Metastatic Breast Cancer
Period
2016 - 2019
Region
Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
87.37 Invested
1.1 mill. Budget
1.2 mill. Partners
University of Copenhagen, Oncology Venture ApS People
Oncology Venture ApS
Read more about the project
| |||